Feedback / Questions
TheraCIM (nimotuzumab) - Daiichi Sankyo, Oncoscience, Biocon
http://clinicaltrials.gov/ct2/show/NCT06413017
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next